| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Current limitations of radiofrequency ablation in renal cell carcinoma
|
Jewett, Michael A. S.
|
|
2004
|
43 |
supplement-3 |
p. 122-123
|
artikel
|
| 2 |
Cytotoxic chemotherapy for metastatic renal cell carcinoma
|
Stadler, Walter M.
|
|
2004
|
43 |
supplement-3 |
p. 145-146
|
artikel
|
| 3 |
Early and late genetic changes in clear cell renal carcinoma
|
Moch, Holger
|
|
2004
|
43 |
supplement-3 |
p. 121
|
artikel
|
| 4 |
Genetic pathways and new progression markers for prostate cancer defined by microsatellite allelotyping
|
Knobloch, Rolf von
|
|
2004
|
43 |
supplement-3 |
p. 149-152
|
artikel
|
| 5 |
HLA class II haplotypes predict favorable outcomes for patients with metastatic RCC
|
Ellerhorst, J. A.
|
|
2004
|
43 |
supplement-3 |
p. 137
|
artikel
|
| 6 |
Human renal cell carcinoma inhibits dendritic cell maturation and functions
|
Song, E. Y.
|
|
2004
|
43 |
supplement-3 |
p. 128-130
|
artikel
|
| 7 |
Immunotherapy in non-renal carcinomas
|
Keilholz, U.
|
|
2004
|
43 |
supplement-3 |
p. 138-140
|
artikel
|
| 8 |
Interferon update
|
Pyrhönen, S.
|
|
2004
|
43 |
supplement-3 |
p. 137-138
|
artikel
|
| 9 |
Metastasectomy for renal cell carcinoma
|
Swanson, D. A.
|
|
2004
|
43 |
supplement-3 |
p. 123-125
|
artikel
|
| 10 |
Molecular pathology of renal cell carcinoma
|
Störkel, S.
|
|
2004
|
43 |
supplement-3 |
p. 118-119
|
artikel
|
| 11 |
Predicting survival of patients with metastatic renal cell carcinoma
|
Motzer, R. J.
|
|
2004
|
43 |
supplement-3 |
p. 135-136
|
artikel
|
| 12 |
Prediction of site-specific metastases in surgically treated nonmetastatic renal cell cancer
|
Frank, I.
|
|
2004
|
43 |
supplement-3 |
p. 125-128
|
artikel
|
| 13 |
Prognostic factors in renal cell carcinoma
|
Ljungberg, Börje
|
|
2004
|
43 |
supplement-3 |
p. 119-120
|
artikel
|
| 14 |
Protein kinase inhibitors: novel tools in cancer therapy
|
Marmé, D.
|
|
2004
|
43 |
supplement-3 |
p. 148
|
artikel
|
| 15 |
Specific monoclonal antibody-based immunotherapy by targeting the RCC-associated antigen carbonic anhydrase-IXG250/MN
|
Mulders, Peter
|
|
2004
|
43 |
supplement-3 |
p. 146-147
|
artikel
|
| 16 |
Target-specific therapy requires target-specific populations in the treatment of renal cell carcinoma
|
Figlin, Robert A.
|
|
2004
|
43 |
supplement-3 |
p. 144-145
|
artikel
|
| 17 |
The cellular and molecular basis of natural antitumor immunity in renal cell carcinoma patients
|
Schendel, Dolores J.
|
|
2004
|
43 |
supplement-3 |
p. 133-135
|
artikel
|
| 18 |
Therapeutic approaches in metastatic renal cell carcinoma: local immunotherapy
|
Huland, Edith
|
|
2004
|
43 |
supplement-3 |
p. 140-144
|
artikel
|
| 19 |
8th Heinrich-Warner-Foundation-Symposium
|
Huland, H.
|
|
2004
|
43 |
supplement-3 |
p. 117
|
artikel
|
| 20 |
Tumor-induced dysfunction in T lymphocytes: increased sensitivity to apoptosis
|
Finke, J. H.
|
|
2004
|
43 |
supplement-3 |
p. 131-132
|
artikel
|
Tijdschrift beschrijving